IL205340A0 - Hcv ns3 protease replicon shuttle vectors - Google Patents

Hcv ns3 protease replicon shuttle vectors

Info

Publication number
IL205340A0
IL205340A0 IL205340A IL20534010A IL205340A0 IL 205340 A0 IL205340 A0 IL 205340A0 IL 205340 A IL205340 A IL 205340A IL 20534010 A IL20534010 A IL 20534010A IL 205340 A0 IL205340 A0 IL 205340A0
Authority
IL
Israel
Prior art keywords
hcv
shuttle vectors
replicon shuttle
protease
protease replicon
Prior art date
Application number
IL205340A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL205340A0 publication Critical patent/IL205340A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2770/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL205340A 2007-12-07 2010-04-26 Hcv ns3 protease replicon shuttle vectors IL205340A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US579207P 2007-12-07 2007-12-07
PCT/EP2008/066417 WO2009071488A2 (en) 2007-12-07 2008-11-28 Hcv ns3 protease replicon shuttle vectors

Publications (1)

Publication Number Publication Date
IL205340A0 true IL205340A0 (en) 2010-12-30

Family

ID=40451400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205340A IL205340A0 (en) 2007-12-07 2010-04-26 Hcv ns3 protease replicon shuttle vectors

Country Status (10)

Country Link
EP (1) EP2220226A2 (en)
JP (1) JP2011505159A (en)
KR (1) KR20100084689A (en)
CN (1) CN101889085A (en)
AU (1) AU2008333339A1 (en)
BR (1) BRPI0821155A2 (en)
CA (1) CA2706659A1 (en)
IL (1) IL205340A0 (en)
MX (1) MX2010005752A (en)
WO (1) WO2009071488A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011023801A1 (en) * 2009-08-31 2011-03-03 F. Hoffmann-La Roche Ag Hcv ns3/4a replicon shuttle vectors
US20110245328A1 (en) * 2010-03-31 2011-10-06 Hyunsoon Kang HCV NS5A Replicon Shuttle Vectors
MX2014000124A (en) * 2011-07-06 2014-02-17 Gilead Sciences Inc Hcv genotype 3 replicons.
EP2729490A1 (en) * 2011-07-06 2014-05-14 Gilead Sciences, Inc. Hcv genotype 4 replicons
JP6562908B2 (en) 2013-10-11 2019-08-21 ヤンセン バイオファーマ インク． Substituted nucleosides, substituted nucleotides and analogs thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801116A1 (en) * 2005-12-21 2007-06-27 F. Hoffmann-La Roche Ag HCV replicon shuttle vectors

Also Published As

Publication number Publication date
MX2010005752A (en) 2010-06-15
WO2009071488A2 (en) 2009-06-11
CA2706659A1 (en) 2009-06-11
KR20100084689A (en) 2010-07-27
JP2011505159A (en) 2011-02-24
WO2009071488A3 (en) 2009-09-24
BRPI0821155A2 (en) 2019-09-24
AU2008333339A1 (en) 2009-06-11
CN101889085A (en) 2010-11-17
EP2220226A2 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
EP2271345A4 (en) Hcv ns3 protease inhibitors
HUS1700001I1 (en) Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
IL189166A0 (en) Macrocyclic peptides as hcv ns3 protease inhibitors
EP2083844A4 (en) Hcv ns3 protease inhibitors
EP2079480A4 (en) Hcv ns3 protease inhibitors
EP2079479A4 (en) Hcv ns3 protease inhibitors
EP2076278A4 (en) Hcv ns3 protease inhibitors
HK1121169A1 (en) Hcv ns3 protease inhibitors hcv ns3
EP1879607A4 (en) Hcv ns3 protease inhibitors
HK1210142A1 (en) Hcv protease inhibitors and uses thereof hcv
HK1210141A1 (en) Hcv protease inhibitors and uses thereof hcv
EP2224942A4 (en) Fluorinated tripeptide hcv serine protease inhibitors
GB0526211D0 (en) Viral vectors
HK1148739A1 (en) Hcv protease inhibitors hcv
EP2618665A4 (en) Hcv ns3 protease inhibitors
EP2027271A4 (en) Recombinant vectors
EP2344648A4 (en) Recombinant vectors
GB0526210D0 (en) Vectors
BRPI0923184A2 (en) hcv ns3 protease inhibitors
EP2432318A4 (en) Bimacrocyclic hcv ns3 protease inhibitors
IL210740A0 (en) Novel viral vector
ZA201001451B (en) Immunomodulatory peptides
SG133558A1 (en) Hcv replicon shuttle vectors
IL225908A0 (en) Novel specific hcv ns3 protease inhibitors
IL205340A0 (en) Hcv ns3 protease replicon shuttle vectors